Novartis Ag (NVS) Net Income (2009 - 2025)

Novartis Ag (NVS) has 15 years of Net Income data on file, last reported at $5.0 billion in Q2 2025.

• Quarterly Net Income rose 13.57% year-over-year to $5.0 billion in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $5.0 billion (down 57.56% YoY) and the FY2025 annual result came in at $14.0 billion, up 16.99% from the prior year.
• Net Income retreated to $5.0 billion in Q2 2025 per NVS's latest filing, from $7.4 billion in the prior quarter.
• The five-year high for Net Income was $34001.4 billion in Q1 2022, with the low at $2.85 in Q4 2023.
• Average Net Income over 5 years is $2269.0 billion, with a median of $1.4 billion recorded in 2021.
• Year-over-year, Net Income sank 100.0% in 2023 and jumped 260877192882.46% in 2024.
• Novartis Ag's Net Income stood at $6.6 billion in 2021, then slumped by 97.71% to $151.0 million in 2022, then slumped by 100.0% to $2.85 in 2023, then jumped by 260877192882.46% to $7.4 billion in 2024, then tumbled by 32.24% to $5.0 billion in 2025.
• Business Quant data shows NVS's Net Income at $5.0 billion in Q2 2025, $7.4 billion in Q4 2024, and $4.4 billion in Q2 2024.